Somerset Trust Company Trimmed Quest Diagnostics (DGX) Position By $550,760; CONVATEC GROUP PLC ORDINARY SHARES UNIT (CNVVF) Sellers Increased By 0.7% Their Shorts

April 24, 2018 - By Michael Collier

Quest Diagnostics Incorporated (NYSE:DGX) Logo

CONVATEC GROUP PLC ORDINARY SHARES UNIT (OTCMKTS:CNVVF) had an increase of 0.7% in short interest. CNVVF’s SI was 1.78M shares in April as released by FINRA. Its up 0.7% from 1.76 million shares previously. The SI to CONVATEC GROUP PLC ORDINARY SHARES UNIT’s float is 0.15%. It closed at $2.8053 lastly. It is down 0.00% since April 24, 2017 and is . It has underperformed by 11.55% the S&P500.

Somerset Trust Company decreased Quest Diagnostics Inc (DGX) stake by 22.9% reported in 2017Q4 SEC filing. Somerset Trust Company sold 5,620 shares as Quest Diagnostics Inc (DGX)’s stock rose 0.72%. The Somerset Trust Company holds 18,917 shares with $1.86M value, down from 24,537 last quarter. Quest Diagnostics Inc now has $13.51 billion valuation. The stock increased 1.31% or $1.29 during the last trading session, reaching $99.45. About 1.66 million shares traded or 50.43% up from the average. Quest Diagnostics Incorporated (NYSE:DGX) has risen 1.33% since April 24, 2017 and is uptrending. It has underperformed by 10.22% the S&P500.

Since January 2, 2018, it had 0 buys, and 13 sales for $30.90 million activity. Shares for $11.43M were sold by RUSCKOWSKI STEPHEN H on Monday, January 29. Another trade for 1,157 shares valued at $119,932 was sold by Klug Robert A. Shares for $40,788 were sold by Doherty Catherine T. on Friday, February 23. PREVOZNIK MICHAEL E had sold 1,423 shares worth $148,576. On Friday, March 2 the insider Davis J. E. sold $517,322. 83,669 shares were sold by Cohen Jon R, worth $8.72M.

Among 21 analysts covering Quest Diagnostics (NYSE:DGX), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Quest Diagnostics has $12300 highest and $68 lowest target. $104.30’s average target is 4.88% above currents $99.45 stock price. Quest Diagnostics had 69 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating by UBS given on Monday, November 14. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Buy” rating given on Thursday, October 19 by Mizuho. The stock of Quest Diagnostics Incorporated (NYSE:DGX) earned “Buy” rating by Mizuho on Wednesday, April 26. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, March 14. The firm has “Buy” rating given on Wednesday, March 7 by Argus Research. The firm has “Neutral” rating given on Friday, October 20 by Citigroup. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Hold” rating given on Thursday, September 28 by Credit Suisse. SunTrust maintained Quest Diagnostics Incorporated (NYSE:DGX) on Thursday, February 1 with “Hold” rating. RBC Capital Markets maintained Quest Diagnostics Incorporated (NYSE:DGX) on Friday, October 23 with “Sector Perform” rating. The rating was maintained by Wells Fargo with “Market Perform” on Friday, October 20.

Quest Diagnostics Incorporated (NYSE:DGX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: